26-Year-Old Woman with Rare and Life-Threating Pregnancy Tumour successfully treated at Fortis Hospital Nagarbhavi

▴ Fortis Hospital Nagarbhavi
Rare Pregnancy Tumors are reported in 2 out of every 1000 Pregnancies.

Bengaluru, 15 January 2026: Doctors at Fortis Hospital, Nagarbhavi successfully treated a Life-threatening pregnancy-related tumour in a 26-year-old woman, while preserving her uterus and fertility. The patient was diagnosed with Gestational Trophoblastic Neoplasia - a rare pregnancy-related tumour characterized by abnormal tissue growth inside the uterus. The tumor posed a high risk of sudden, severe internal bleeding if not handled with extreme caution. The rare case was managed through a multi-disciplinary approach led by Dr. Nirmala Chandrashekar, Consultant – Obstetrics & Gynaecology, Fortis Hospital, Nagarbhavi.

When admitted at Fortis Nagarbhavi, the patient was presented with complaints of missed abortion (a type of miscarriage where the pregnancy has stopped developing) and continuous vaginal spotting. Her ultrasound scans showed abnormal intrauterine mass with significantly increased blood flow. In such cases, emergency removal of the uterus becomes necessary to save the patient’s life. Given the gravity of the situation, the patient’s family initially requested hysterectomy. However, after thorough evaluation, the Fortis Nagarbhavi medical team opted for a carefully planned, step-by-step conservative approach aimed at preserving the patient’s fertility.

The team of doctors, first performed a procedure to temporarily block blood supply to the uterus, significantly reducing the risk of massive bleeding. This was followed by a meticulously monitored removal of the abnormal tissue under ultrasound guidance. The patient responded well to the treatment, experienced no major complications, and recovered smoothly. Subsequent tests confirmed a partial molar pregnancy, a rare but treatable condition. After treatment, the patient’s pregnancy hormone levels returned to normal, confirming complete recovery without the need for uterus removal.

Giving details of the case, Dr Nirmala Chandrashekar, Consultant – Obstetrics & Gynaecology, Fortis Hospital, Nagarbhavi said, “This was an extremely challenging case due to the high risk of sudden and severe bleeding. Our foremost priority was to save the patient’s life while making every possible effort to preserve her uterus. By carefully reducing uterine blood flow first and then removing the abnormal tissue under ultrasound guidance, we were able to achieve a safe and fertility-preserving outcome.”

Expressing her gratitude, the patient said, “I feared the worst, but I never imagined it could be so serious. The doctors at Fortis Nagarbhavi explained everything patiently and treated me with great care. I am deeply grateful that my life was saved and that my ability to have children in the future has been conserved.”

Mr Ratheef Naik, Facility Director, Fortis Hospital, Nagarbhavi, added, “Gestational trophoblastic tumours demand early diagnosis and coordinated multidisciplinary expertise. At Fortis Nagarbhavi, we are equipped to deliver advanced, conservative and fertility-preserving care when patients seek timely treatment. This successful intervention once again reinforces our position as a leading tertiary care centre for managing high-risk and complex obstetric conditions, combining clinical excellence with compassionate, patient-centric care.”

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

The Value of Risk Communication in Public HealthOctober 08, 2026
What Makes a Reliable Health Screening Programme?October 08, 2026
How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
AI and Patient Consent in India: Who Is Responsible?October 06, 2026
Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026